Factor | AOR (95% CI) |
---|---|
Consultation type | |
Follow-up | 1 |
First | 1.65 (1.52 - 1.79)* |
Physician specialization | |
GP | 1 |
Internal medicine | 1.49 (1.40 - 1.58)* |
Other | 0.76 (0.70 - 0.84)* |
Age (y)** | 0.97 (0.97 - 0.98)* |
Sex | |
male | 1 |
female | 1.35 (1.27 - 1.43)* |
Diagnosis (groups) | |
Hypertensive diseases [I10-I15] | 0.36 (0.32 - 0.39)* |
Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, and related tissue [C00-C75] | 4.54 (4.12 - 4.99)* |
Malignant neoplasms of ill-defined, secondary, and unspecified sites [C76-C80] | 2.90 (2.54 - 3.30)* |
Arthropathies [M00-M25] | 1.36 (1.19 - 1.55)* |
Chronic lower respiratory diseases [J40-J47] | 0.59 (0.50 - 0.69)* |
Diabetes mellitus [E10-E14] | 0.17 (0.14 - 0.22)* |
Episodic and paroxysmal disorders [G40-G47] | 0.53 (0.45 - 0.63)* |
Ischaemic heart diseases [I20-I25] | 0.71 (0.60 - 0.83)* |
Extrapyramidal and movement disorders [G20-G26] | 0.46 (0.37 - 0.58)* |
Dorsopathies [M40-M54] | 1.34 (1.16 - 1.55)* |
Metabolic disorders [E70-E90] | 0.17 (0.13 - 0.22)* |
Disorders of thyroid gland [E00-E07] | 0.54 (0.45 - 0.64)* |
Interaction terms | |
Hypertensive diseases [I10-I15] * age | 1.03 (1.02 - 1.04)* |
Extrapyramidal and movement disorders [G20-G26] * age | 1.04 (1.02 - 1.07)* |